(19)
(11) EP 2 788 014 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
23.10.2019 Bulletin 2019/43

(45) Mention of the grant of the patent:
18.09.2019 Bulletin 2019/38

(21) Application number: 12855593.5

(22) Date of filing: 07.12.2012
(51) International Patent Classification (IPC): 
A61P 19/02(2006.01)
A61P 21/06(2006.01)
 A61P 19/04(2006.01)
A61K 38/27(2006.01)
(86) International application number:
PCT/AU2012/001497
(87) International publication number:
WO 2013/082667 (13.06.2013 Gazette 2013/24)

(54)

USE OF GROWTH HORMONE FRAGMENTS

VERWENDUNG VON WACHSTUMSHORMONFRAGMENTEN

UTILISATION DE FRAGMENTS D'HORMONE DE CROISSANCE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 09.12.2011 AU 2011905132
09.12.2011 AU 2011905133
10.04.2012 AU 2012901398
10.04.2012 AU 2012901400

(43) Date of publication of application:
15.10.2014 Bulletin 2014/42

(73) Proprietor: Metabolic Pharmaceuticals Pty Ltd
Melbourne VIC 3000 (AU)

(72) Inventor:
  • KENLEY, David
    Caulfield North, Victoria 3161 (AU)

(74) Representative: Wise, Daniel Joseph et al
Carpmaels & Ransford LLP One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A1-99/12969
WO-A1-2005/014033
WO-A1-2006/133477
US-A1- 2010 197 590
 WO-A1-03/092725
WO-A1-2005/105132
WO-A2-2006/014678
   
  • SANG BEOM KIM ET AL: "Additive Effects of Intra-articular Injection of Growth Hormone and Hyaluronic Acid in Rabbit Model of Collagenase-induced Osteoarthritis", JOURNAL OF KOREAN MEDICAL SCIENCE, vol. 25, no. 5, 1 January 2010 (2010-01-01), page 776, XP055213604, ISSN: 1011-8934, DOI: 10.3346/jkms.2010.25.5.776
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).